Journey Medical (DERM) Return on Assets (2021 - 2025)
Journey Medical (DERM) has disclosed Return on Assets for 5 consecutive years, with 0.1% as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Return on Assets rose 18.0% year-over-year to 0.1%, compared with a TTM value of 0.1% through Sep 2025, up 18.0%, and an annual FY2024 reading of 0.19%, down 14.0% over the prior year.
- Return on Assets was 0.1% for Q3 2025 at Journey Medical, up from 0.1% in the prior quarter.
- Across five years, Return on Assets topped out at 0.01% in Q2 2024 and bottomed at 0.47% in Q2 2023.
- Average Return on Assets over 5 years is 0.24%, with a median of 0.24% recorded in 2024.
- Peak annual rise in Return on Assets hit 49bps in 2024, while the deepest fall reached -15bps in 2024.
- Year by year, Return on Assets stood at 0.47% in 2021, then skyrocketed by 41bps to 0.28% in 2022, then soared by 81bps to 0.05% in 2023, then crashed by -275bps to 0.2% in 2024, then soared by 49bps to 0.1% in 2025.
- Business Quant data shows Return on Assets for DERM at 0.1% in Q3 2025, 0.1% in Q2 2025, and 0.1% in Q1 2025.